logo

For the Inventor, By the Inventor

Deerfield, IL, United States of America

Ragab El-Rashidy

USPTO Granted Patents = 22

Average Co-Inventor Count = 1.8

ph-index = 15

Forward Citations = 558(Granted Patents)


Company Filing History:

goldMedal17 out of 18 
 
Pentech Pharmaceuticals, Inc.
 patents
silverMedal2 out of 415 
 
Queen's University at Kingston
 patents
bronzeMedal2 out of 2 
 
Genix Therapeutics Group, LLC
 patents
4. 1 out of 6 
 
Gynex, Inc.
 patents
5. 1 out of 2 
 
Pharmedic Co.
 patents
6. 1 out of 832,761 
Other
 patents
where one patent can have more than one assignee

Years Active: 1989-2016

Loading Chart...
22 patents (USPTO):Explore Patents
1. 9408865 - Treatment of huntington'S disease (2016-08-09),
2. 8889125 - Treatment of Huntington's disease (2014-11-18),
3. 6638948 - Amorphous paroxetine composition (2003-10-28),
4. 6566368 - Apomorphine-containing dosage form for ameliorating male erectile dysfunction (2003-05-20),
5. 6503927 - Amorphous paroxetine composition (2003-01-07),
6. 6306437 - Apomorphine-containing dosage forms for ameliorating male erectile dysfunction (2001-10-23),
7. 6200983 - Dosage forms containing apomorphine for ameliorating male erectile dysfunction (2001-03-13),
8. 6193992 - Female sexual dysfunction treatment (2001-02-27),
9. 6121276 - Apomorphine-containing dosage forms for ameliorating male erectile (2000-09-19),
10. 6087362 - Apomorphine and sildenafil composition (2000-07-11),
11. 5994363 - Amelioration of apomorphine adverse effects (1999-11-30),
12. 5985889 - Dosage forms and method for ameliorating male erectile dysfunction (1999-11-16),
13. 5945117 - Treatment of female sexual dysfunction (1999-08-31),
14. 5939094 - Transdermal administration of apomorphine (1999-08-17),
15. 5888534 - Controlled release of drugs delivered by sublingual or buccal (1999-03-30),

Title: Ragab El-Rashidy: Innovator in the Treatment of Huntington's Disease

Introduction

Ragab El-Rashidy, based in Deerfield, IL, is an accomplished inventor with an impressive portfolio comprising 22 patents. His work primarily focuses on groundbreaking treatments for serious medical conditions, particularly Huntington's disease, showcasing his commitment to advancing healthcare through innovation.

Latest Patents

Among Ragab's most significant contributions are his latest patents related to the treatment of Huntington's disease. These inventions outline a method for ameliorating the symptoms of this debilitating condition. The process involves administering an effective amount of adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier, ideally through intramuscular injection. This innovative approach marks a substantial advancement in potential treatments available for individuals suffering from Huntington's disease.

Career Highlights

Ragab has had a rich career marked by his positions in reputable companies, including Pentech Pharmaceuticals, Inc. and Queen's University at Kingston. Through these roles, he has not only contributed his expertise but has also furthered the development of novel solutions in the medical field.

Collaborations

Throughout his career, Ragab has collaborated with talented individuals, including colleagues Bruce Ronsen and Alvaro Morales. These partnerships have facilitated the exchange of ideas and fostered an environment of innovation, further enhancing the quality and reach of his inventions.

Conclusion

Ragab El-Rashidy stands out as a notable inventor who is significantly impacting the medical field through his innovative approaches to treating Huntington's disease. With 22 patents to his name, his work exemplifies the blend of scientific inquiry and practical application that is essential in advancing healthcare solutions. His contributions not only benefit individuals dealing with specific health issues but also inspire ongoing research and development in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…